Caliway Biopharmaceuticals , Ltd. Total Current Liabilities

As of the most recent data (March 2026), 6919.TWO shows a total current liabilities of $110M. That compares with $77M in the prior-year period — up 45.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6919.TWO's total current liabilities is now $110M (was $77M) — a 45.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Caliway Biopharmaceuticals , Ltd. is outperforming or lagging.

Tracking 6919.TWO's total current liabilities over time shows whether Caliway Biopharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $77M in the prior-year period — up 45.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Caliway Biopharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $110M) with ownership activity and broader fundamentals.

Caliway Biopharmaceuticals , Ltd.'s total current liabilities is $110M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.